Table 1.
Schedule of activities
Follow-up visits | ||||||||
PROTOCOL ACTIVITIES | Screening Visit | Initial Visit | Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Final Visit |
SCHEDULE OF VISITS | 0 | 15 ± 5 | 30 ± 5 | 45 ± 5 | 60 ± 5 | 75 ± 5 | 90 ± 5 | |
Clinical History | X | X | X | X | X | X | X | X |
Physical Examination | X | X | X | X | X | X | X | X |
Inclusion/Exclusion criteria | X | |||||||
Informed Consent | X | |||||||
Clinical assessment of vascular compromise | X | X | X | X | X | X | X | X |
Clinical assessment of neuropathic compromise | X | X | ||||||
Laboratory tests | X | X | ||||||
Ankle/arm index | X | |||||||
Randomization | X | |||||||
Treatment administration | X | X | X | X | X | X | ||
Clinical assessment of the lesion | X | X | X | X | X | X | X | X |
Measurement of ulcers | X | X | X | X | X | X | X | X |
Photographic registration | X | X | X | X | X | X | X | |
Education of patients | X | X | X | X | X | X | X | X |
Documentation of adverse events | X | X | X | X | X | X | X | X |
Recording of concomitant medications | X | X | X | X | X | X | X | X |